Status:
COMPLETED
Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
Lead Sponsor:
Haiyan Wang
Conditions:
End Stage Renal Disease
Arteriovenous Fistula
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective cohort study aimed at evaluating the impact of autologous arteriovenous fistula (AVF) on the heart, especially the left atrial structure, in patients with end-stage renal...
Detailed Description
1. Retrospective collection of ESRD patients who visited the Department of Nephrology at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province) fro...
Eligibility Criteria
Inclusion
- ① Meets the diagnostic criteria for chronic kidney disease; ② Age ≥ 18 years old; ③ Regular dialysis patients; ④ Using AVF or TCC as the sole vascular pathway.
Exclusion
- ① Irregular dialysis patients; ② High output states such as hyperthyroidism; ③ Basic heart diseases (cardiomyopathy, severe valvular disease, intracardiac shunting, constrictive pericarditis, post heart transplant, etc.)
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
2027 Patients enrolled
Trial Details
Trial ID
NCT06199609
Start Date
September 1 2022
End Date
November 30 2023
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China, 250000